Kronox LAB Sciences LTD
₹207.28▼ -10.90 (-5.00%)
KRONOX·NSE·Chemicals
Market Cap
776.03 Cr
PE Ratio
27.60
Volume
56,685
Day High - Low
217.99 - 207.28
52W High-Low
227.74 - 96.00
₹207.28▼ -10.90 (-5.00%)
Market Cap776.03 Cr
PE Ratio27.60
Volume56,685
Day High - Low217.99 - 207.28
52W High-Low227.74 - 96.00
Kronox Lab Sciences Ltd (KRONOX): company summary
The company's annual revenue rose 1.2% to ₹101 crore, while annual net profit rose 10.6% to ₹28 crore.
Kronox Lab Sciences Ltd (KRONOX) is a micro-cap Chemicals company valued at ₹776 crore operating in Specialty Chemicals on the NSE and BSE.
- Recent price move
- Kronox Lab Sciences Ltd last traded at ₹207.28, sharply down 5.00% on the day.
- Recent developments
- 2026-09-29: The company's chairman and managing director, Mr. Jogindersingh Jaswal, resigned effective September 29, 2026. 2026-08-20: Indo Borax & Chemicals acquired a 64.26% controlling stake in the company for ₹246.12 crore at ₹103.22 per share, followed by a mandatory open offer for 25.79% at ₹157.27 per share.
- Financial performance
- The company's annual revenue rose 1.2% to ₹101 crore, while annual net profit rose 10.6% to ₹28 crore. The latest quarter saw revenue rise 16.9% to ₹28 crore and net profit rise 16.2% to ₹7 crore, with net profit margin expanding 2.3 percentage points to 27.3%.
- Valuation multiples
- The stock trades at 27.6 times earnings, 5.52 times book value. It yields 0.3%.
- Things to watch
- The stock is 9.6% below its 52-week high. The company's promoter holding remains at 74.21%, with no change in the quarter. The last price fell 4.90% on the day.
- Where it stands
- The company's latest quarter revenue and net profit both rose compared to the same quarter a year earlier. The stock is 9.6% below its 52-week high, and the company's promoter holding remains unchanged at 74.21%.
Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
DocStoX Score
6.8/10
Fair
Fair Value
Sign in to see
ROE
23.82%
Strong
P/E
27.60x
Fair
Debt / Equity
0.01
Low
Industry
Chemicals
Specialty Chemicals
Overall View
Mixed
Price performance
Day₹207.28
₹217.99
52W₹96.00
₹227.74
DocStoX take
Supported by quality (8.9) and risk (8.1), but held back by valuation (2.6). Quality looks strong at 8.9, but that is offset by valuation at 2.6. We are calling it Mixed rather than resolving the conflict for you.
DocStoX score
Low confidence6.8
/10
Fair
Quality
Excellent
ROE 23.8%
Valuation
Expensive
P/E 27.6×
Growth
Steady
Revenue +10.3% 5Y CAGR
Risk
Low risk
D/E 0.01
Momentum
Strong
84% of 52-week range
At a glance
Market Cap
₹776 Cr
52W High / Low
₹228 / ₹96
Dividend Yield
0.29%
Promoter Holding
74.21%
EPS (TTM)
₹7.51
Book Value
₹31.30
Key highlights
- Capital works hard — ROCE 32%
- Low leverage — D/E 0.01
- Profitable in all of the last 5 years
- Small ₹776 cr company — thinner liquidity
4 Positives1 Watchout
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Chemicals stocks · Specialty Chemicals
Explore KRONOX LAB SCIENCES LTD’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
KRONOX LAB SCIENCES LTD peers in Chemicals
Other Chemicals stocks on the NSE & BSE. See the full Chemicals sector list.
Related tools & concepts
Value KRONOX LAB SCIENCES LTD with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing